EDIL3 and neoplasm: The mRNA level in tumors positive for EDIL3 immunohistochemistry was higher than that in tumor-free control lung samples (p = 0.06, Fig. 2) and tumors without EDIL3 immunohistochemical positivity (p = 0.057, Fig. 2).